Events

RheaVita is one of the winners of the CPHI Pharma Awards 2024.

We won in the category “Manufacturing Excellence” for the launch of our RheaLyo™ GMP-Flex continuous freeze-dryer.

We are incredibly proud for being recognised for our innovation and excellence. A big thank you to CPHI and the judges.

With our innovations and achievements we are redefining pharmaceutical lyophilisation.

Discover our Next Generation controlled, continuous RheaLyo™ freeze-drying technology.
Check out our booth #18C85 to watch a live demo.
From 8-10 October, our process specialists will be glad to present the latest developments:
RheaLyo™ Mono freeze-dryer: Our Single Vial Unit for R&D. Fast and optimal formulation and process development. Now with BSL2 integration!
RheaLyo™ Multi freeze-dryer: Our Multi Vial Unit for non-GMP stability study productions.
RheaLyo™ GMP-Flex production lines: For clinical and commercial productions.
Get exclusive insights on RheaVita’s way to Continuous Lyophilization and discover how this technology may drive your economics, quality and flexibility.

RheaVita: we take the pain out of biopharmaceutical freeze-drying.

On March 14 & 15 we attended the Advanced Therapies Congress in London where we presented a new poster on avoiding cold chain logistic challenges by using freeze-drying to stabilize gene therapies. The poster can be viewed here.

Reach out to us via info@rheavita.com if you wish to book a meeting or would like to learn more about freeze-drying of gene therapies or other ATMPs.

More info on the event can be found here: Advanced Therapies

RheaVita will participate in the 7th Commercializing Continuous Processing in Pharma Summit in Boston. There we will present a poster on “Implementing PAT during continuous freeze-drying allows real-time monitoring and control of relevant Critical Quality Attributes providing the potential for real-time release.”

The conference will take place in Boston from March 7 to 9, 2023.

More info can be found here.

The first exhibition of the year we will participate in is PharmaPack Europe, Paris Expo, Porte de Versailles – Hall 7.2. Taking place February 1&2 in Paris, France.

Reach out to us via info@rheavita.com if you wish to book a meeting.

More info on the event can be found here: PharmaPack Europe

Our business development director, Jan Van Hauwermeiren, will represent RheaVita at CPHI taking place November 1-3 2022 in Frankfurt.

Be sure to connect with him via info@rheavita.com for a face-to-face meeting. He will gladly discuss our latest advancements, CDO services or continuous manufacturing with you.

All information about CPHI can be found here.

We attended the BIOPROCESS INTERNATIONAL and CELL & GENE THERAPY MANUFACTURING & COMMERCIALIZATION conference in Boston (September 27-30, 2022). If you wish to know more about how to increase the long-term stability and simplify the cold chain logistics of your drug product feel free to reach out to him!

We attended the 2022 PDA BioManufacturing Conference taking place from September 20 until 21 in Amsterdam.

Together with J&J we presented data and results from our collaboration over the past 2 years.

More info and a full agenda can be found here: PDA BioManufacturing Conference